These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34174273)

  • 1. Novel treatments for autism spectrum disorder based on genomics and systems biology.
    Baribeau D; Anagnostou E
    Pharmacol Ther; 2022 Feb; 230():107939. PubMed ID: 34174273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for autism in 2017 and the consequential implications to drug discovery.
    Chadman KK
    Expert Opin Drug Discov; 2017 Dec; 12(12):1187-1194. PubMed ID: 28971687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic strategies to untangle the etiology of autism: A primer.
    Vashisth S; Chahrour MH
    Autism Res; 2023 Jan; 16(1):31-39. PubMed ID: 36415077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs in early-stage clinical trials for autism spectrum disorder.
    Hong MP; Erickson CA
    Expert Opin Investig Drugs; 2019 Aug; 28(8):709-718. PubMed ID: 31352835
    [No Abstract]   [Full Text] [Related]  

  • 5. Do animal models hold value in Autism spectrum disorder (ASD) drug discovery?
    Chadman KK; Fernandes S; DiLiberto E; Feingold R
    Expert Opin Drug Discov; 2019 Aug; 14(8):727-734. PubMed ID: 31132011
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarker discovery for disease status and symptom severity in children with autism.
    Oztan O; Jackson LP; Libove RA; Sumiyoshi RD; Phillips JM; Garner JP; Hardan AY; Parker KJ
    Psychoneuroendocrinology; 2018 Mar; 89():39-45. PubMed ID: 29309996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanisms and treatment approaches in autism spectrum disorder.
    Brian J; Doyle-Thomas K; Baribeau D; Anagnostou E
    Discov Med; 2016 Aug; 22(119):47-54. PubMed ID: 27585230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating precision medicine for autism spectrum disorder: A pressing need.
    Pérez-Cano L; Azidane Chenlo S; Sabido-Vera R; Sirci F; Durham L; Guney E
    Drug Discov Today; 2023 Mar; 28(3):103486. PubMed ID: 36623795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic architecture of autism spectrum disorder: Lessons from large-scale genomic studies.
    Choi L; An JY
    Neurosci Biobehav Rev; 2021 Sep; 128():244-257. PubMed ID: 34166716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological implications of genetic variations in autism spectrum disorders from genomics studies.
    Zhang Y; Liu X; Guo R; Xu W; Guo Q; Hao C; Ni X; Li W
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34240107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Bioinformatics Methods for Analyzing Autism Spectrum Disorders.
    Nakashima S; Nacher JC; Song J; Akutsu T
    Curr Pharm Des; 2020; 25(43):4552-4559. PubMed ID: 31713477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
    Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
    J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program.
    Jacob S; Anagnostou E; Hollander E; Jou R; McNamara N; Sikich L; Tobe R; Murphy D; McCracken J; Ashford E; Chatham C; Clinch S; Smith J; Sanders K; Murtagh L; Noeldeke J; Veenstra-VanderWeele J
    Mol Autism; 2022 Jun; 13(1):25. PubMed ID: 35690870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and genomics of autism spectrum disorder: embracing complexity.
    De Rubeis S; Buxbaum JD
    Hum Mol Genet; 2015 Oct; 24(R1):R24-31. PubMed ID: 26188008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
    Aishworiya R; Valica T; Hagerman R; Restrepo B
    Neurotherapeutics; 2022 Jan; 19(1):248-262. PubMed ID: 35029811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
    Lacivita E; Perrone R; Margari L; Leopoldo M
    J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
    Liu H; Talalay P; Fahey JW
    CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiated Approach to Pharmacotherapy of Autism Spectrum Disorders: Biochemical Aspects.
    Boksha IS; Prokhorova TA; Tereshkina EB; Savushkina OK; Burbaeva GS
    Biochemistry (Mosc); 2023 Mar; 88(3):303-318. PubMed ID: 37076279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder.
    Pandina G; Ring RH; Bangerter A; Ness S
    Child Adolesc Psychiatr Clin N Am; 2020 Apr; 29(2):301-317. PubMed ID: 32169264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.